ArticleiScience2024
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.
Amy R Leslie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleiScience2024
Amy R Leslie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.